801
Participants
Start Date
February 21, 2019
Primary Completion Date
December 31, 2022
Study Completion Date
December 31, 2027
Hypofractionated radiotherapy
4005 cGy/ 15 fractions / 3 weeks to ipsilateral chest wall or whole breast and regional lymph regions (including supraclavicular and internal mammary lymph nodes) and sequential tumor bed boost of 2.67Gy for 4 fractions in patients with intact breast
Conventional radiotherapy
5000 cGy/ 25 fractions / 5 weeks ipsilateral chest wall or whole breast and regional lymph regions (including supraclavicular and internal mammary lymph nodes) and sequential tumor bed boost of 2Gy for 5 fractions in patients with intact breast
RECRUITING
Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai
RenJi Hospital
OTHER
Shanghai 10th People's Hospital
OTHER
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
OTHER
Shanghai Zhongshan Hospital
OTHER
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
OTHER
Affiliated Hospital of Jiangnan University
OTHER
Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)
UNKNOWN
The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China
OTHER
Ruijin Hospital
OTHER